Myth: A non-malignant brain tumour diagnosis provides relief to the person diagnosed and their family.
The distinction between non-malignant and malignant brain tumours can be challenging. Some non-malignant tumours can be as serious as those classified as malignant if they are in an inaccessible location, such as the brain stem. Any brain tumour is life-changing regardless of grade or stage.
Myth: All brain tumour patients have the same signs and symptoms.
Every person diagnosed with a brain tumour will have different symptoms and their own journey to a diagnosis. While some people do not develop symptoms that would indicate a tumour, others may have symptoms that worsen over time eventually leading to a diagnosis. Other still may feel perfectly fine but experience a sudden onset of symptoms, such as a seizure which leads to a quick and unexpected tumour diagnosis.
Myth: Someone diagnosed with a non-malignant brain tumour does not require chemotherapy.
Although it is seldom required, someone with a non-malignant brain tumour may require chemotherapy. Treatment protocols are based on the person’s age and overall condition, and the location and size of the tumour.
Myth: Once a patient finishes their treatment plan, life goes back to ‘normal’.
For some patients, there comes a day when active treatment ends. That day can bring with it numerous mixed feelings, relief, happiness, anxiety but also uncertainty. The end of treatment does not mean the end of the experience of having a brain tumour and the person may need to adapt to a “new normal” depending on long-term effects the person may have from treatment.
Myth: Brain tumours are a rare form of cancer.
Brain tumours are the leading cause of solid cancer death in children under the age of 20, now surpassing leukemia. They are the third leading cause of solid cancer death in young adults ages 20-39.
Myth: Treatment for a brain tumour is standard and accessible to anyone affected.
The treatment of a brain tumour can vary widely depending on the type (there are 120 different ones) and location of a brain tumour, the age of a patient and many other individual elements. While treatment should be defined by an individual’s medical needs, it should never be determined by cost or geographic location. Equal access to treatments and drugs and the associated financial burden is an important issue for brain tumour patients and their families in Canada.
Myth: People who have family members who have brain tumors are more likely to get brain cancer.
There is no proof that heredity is a factor that contributes to brain cancer development. 
Myth: You can get brain cancer from the radiation that cell phones emit, or from consuming aspartame.
There is no evidence that cell phone use causes brain cancer. No toxicological studies have offered proof to support the rumours surrounding aspartame. 
Information taken from Brain Tumour Foundation of Canada unless otherwise indicated.
 Choose Hope Blog, “May is Brain Cancer Awareness Month – Myths & Facts You Should Know”, https://www.choosehope.com/blog/may-is-brain-cancer-awareness-month-myths-and-facts-you-should-know/